Cargando…
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam
BACKGROUND: Newly diagnosed patients without anti-tuberculosis (TB) treatment histories have not often undergone drug susceptibility testing (DST), but have received the standard treatment regimen without information about their DST profiles in many countries with inadequate resources. METHODS: We c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228276/ https://www.ncbi.nlm.nih.gov/pubmed/24188178 http://dx.doi.org/10.1186/1756-0500-6-444 |
_version_ | 1782343949544849408 |
---|---|
author | Hung, Nguyen Van Ando, Hiroki Thuy, Tran Thi-Bich Kuwahara, Tomoko Hang, Nguyen Thi-Le Sakurada, Shinsaku Thuong, Pham Huu Lien, Luu Thi Keicho, Naoto |
author_facet | Hung, Nguyen Van Ando, Hiroki Thuy, Tran Thi-Bich Kuwahara, Tomoko Hang, Nguyen Thi-Le Sakurada, Shinsaku Thuong, Pham Huu Lien, Luu Thi Keicho, Naoto |
author_sort | Hung, Nguyen Van |
collection | PubMed |
description | BACKGROUND: Newly diagnosed patients without anti-tuberculosis (TB) treatment histories have not often undergone drug susceptibility testing (DST), but have received the standard treatment regimen without information about their DST profiles in many countries with inadequate resources. METHODS: We collected 346 clinical isolates from previously untreated patients with smear-positive active TB in Hanoi, the capital of Vietnam. Of these, 339 were tested for susceptibility to four first-line anti-TB drugs, including isoniazid (INH), rifampicin (RMP), streptomycin (SM), and ethambutol (EMB), using the proportion method. A pyrazinamidase (PZase) test was used to assess pyrazinamide (PZA) resistance. Results of the culture-based drug susceptibility tests were confirmed by those from reverse hybridization-based line probe assays (LiPAs) that detected mutations associated with RMP, INH, PZA, and fluoroquinolone (FQ) resistance. To investigate a diversity of these strains, IS6110-probed restriction fragment length polymorphisms (RFLPs) were analyzed. Nucleotide sequences for furA-katG and fabG1-inhA operons, transcription units responsible for INH resistance, were also determined. RESULTS: Of the isolates tested, 127 (37.5%) were resistant to at least one of the four drugs, which included 93 (27.4%) isolates that were resistant to INH. RFLP analysis identified four clusters defined by similarity of the band patterns, which accounted for 46.1% of the tested isolates. Among the clustered isolates, 37.7% were resistant to INH, most of which (85.4%) carried a g944c mutation, which causes an S315T amino acid substitution, in the katG gene. CONCLUSIONS: Our results suggest that drug-resistant strains, particularly those with INH resistance characterized by a single mutation, S315T, are spreading in Hanoi, Vietnam. When RMP resistance is combined with this setting, patients are not easily cured by conventional short-term treatment. We will need to carefully monitor these trends and search for the origins and transmission routes of these strains. |
format | Online Article Text |
id | pubmed-4228276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42282762014-11-13 Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam Hung, Nguyen Van Ando, Hiroki Thuy, Tran Thi-Bich Kuwahara, Tomoko Hang, Nguyen Thi-Le Sakurada, Shinsaku Thuong, Pham Huu Lien, Luu Thi Keicho, Naoto BMC Res Notes Research Article BACKGROUND: Newly diagnosed patients without anti-tuberculosis (TB) treatment histories have not often undergone drug susceptibility testing (DST), but have received the standard treatment regimen without information about their DST profiles in many countries with inadequate resources. METHODS: We collected 346 clinical isolates from previously untreated patients with smear-positive active TB in Hanoi, the capital of Vietnam. Of these, 339 were tested for susceptibility to four first-line anti-TB drugs, including isoniazid (INH), rifampicin (RMP), streptomycin (SM), and ethambutol (EMB), using the proportion method. A pyrazinamidase (PZase) test was used to assess pyrazinamide (PZA) resistance. Results of the culture-based drug susceptibility tests were confirmed by those from reverse hybridization-based line probe assays (LiPAs) that detected mutations associated with RMP, INH, PZA, and fluoroquinolone (FQ) resistance. To investigate a diversity of these strains, IS6110-probed restriction fragment length polymorphisms (RFLPs) were analyzed. Nucleotide sequences for furA-katG and fabG1-inhA operons, transcription units responsible for INH resistance, were also determined. RESULTS: Of the isolates tested, 127 (37.5%) were resistant to at least one of the four drugs, which included 93 (27.4%) isolates that were resistant to INH. RFLP analysis identified four clusters defined by similarity of the band patterns, which accounted for 46.1% of the tested isolates. Among the clustered isolates, 37.7% were resistant to INH, most of which (85.4%) carried a g944c mutation, which causes an S315T amino acid substitution, in the katG gene. CONCLUSIONS: Our results suggest that drug-resistant strains, particularly those with INH resistance characterized by a single mutation, S315T, are spreading in Hanoi, Vietnam. When RMP resistance is combined with this setting, patients are not easily cured by conventional short-term treatment. We will need to carefully monitor these trends and search for the origins and transmission routes of these strains. BioMed Central 2013-11-05 /pmc/articles/PMC4228276/ /pubmed/24188178 http://dx.doi.org/10.1186/1756-0500-6-444 Text en Copyright © 2013 Hung et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Hung, Nguyen Van Ando, Hiroki Thuy, Tran Thi-Bich Kuwahara, Tomoko Hang, Nguyen Thi-Le Sakurada, Shinsaku Thuong, Pham Huu Lien, Luu Thi Keicho, Naoto Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam |
title | Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam |
title_full | Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam |
title_fullStr | Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam |
title_full_unstemmed | Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam |
title_short | Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam |
title_sort | clonal expansion of mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in hanoi, vietnam |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228276/ https://www.ncbi.nlm.nih.gov/pubmed/24188178 http://dx.doi.org/10.1186/1756-0500-6-444 |
work_keys_str_mv | AT hungnguyenvan clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam AT andohiroki clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam AT thuytranthibich clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam AT kuwaharatomoko clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam AT hangnguyenthile clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam AT sakuradashinsaku clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam AT thuongphamhuu clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam AT lienluuthi clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam AT keichonaoto clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam |